- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Beta Bionics receives FDA warning letter | 3 | MassDevice | ||
| Mo | Beta Bionics: TD Cowen bleibt trotz FDA-Warnung bei "Hold"-Einstufung | 1 | Investing.com Deutsch | ||
| Mo | TD Cowen reiterates Hold rating on Beta Bionics stock amid FDA warning letter | 2 | Investing.com | ||
| Mo | FDA-Warnung an Beta Bionics: TD Cowen hält an Kursziel von 17 US-Dollar fest | 2 | Investing.com Deutsch | ||
| Mo | Beta Bionics stock holds steady as TD Cowen reiterates $17 price target | 1 | Investing.com | ||
| Mo | Truist Securities lowers Beta Bionics stock price target to $25 from $37 | 1 | Investing.com | ||
| 30.01. | Beta Bionics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 27.01. | Beyond The Numbers: 4 Analysts Discuss Beta Bionics Stock | 1 | Benzinga.com | ||
| BETA BIONICS Aktie jetzt für 0€ handeln | |||||
| 27.01. | Beta Bionics: TD Cowen startet Coverage mit "Halten"-Einstufung | 2 | Investing.com Deutsch | ||
| 27.01. | Beta Bionics stock initiated with Hold rating at TD Cowen | 1 | Investing.com | ||
| 15.01. | Beta Bionics, Inc.: Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 | 2 | GlobeNewswire (USA) | ||
| 09.01. | Beta Bionics Shares Tumble 33% | 2 | RTTNews | ||
| 09.01. | Beta Bionics Key KPI Miss Targets, Analyst Flags Valuation Risks | 1 | Benzinga.com | ||
| 09.01. | Analysts downgrade Beta Bionics on new patient starts miss | 3 | MassDevice | ||
| 09.01. | BofA Securities downgrades Beta Bionics stock to Neutral on valuation concerns | 2 | Investing.com | ||
| 08.01. | Beta Bionics reports Strong Preliminary Q4 2025 Topline Growth | 1 | Seeking Alpha | ||
| 08.01. | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | 392 | GlobeNewswire (Europe) | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| 08.01. | Beta Bionics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 08.12.25 | Beta Bionics, Inc.: Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 | 1 | GlobeNewswire (USA) | ||
| 29.10.25 | Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion | 2 | Seeking Alpha |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,440 | +1,65 % | Picks and shovels play intact, chg.: FY25 prelims confirm Eckert & Ziegler's earnings momentum, with China and isotope ... | Novo Nordisk's c.17% share price drop underscores how quickly sentiment can turn in single product healthcare stories, especially when patent cycle concerns resurface. In contrast, EUZ is "picks and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | Hims & Hers-Aktie -10%: Warum profitiert sie nicht? | Die Hims & Hers-Aktie schoss am gestrigen Donnerstag kurzfristig um über +10% in die Höhe, beendete den Handelstag dann aber doch mit einem Minus von fast -4%. Am Freitagmorgen bricht der Kurs der Gesundheitsplattform... ► Artikel lesen | |
| RADNET | 59,00 | 0,00 % | RadNet, Inc.: RadNet Enters Indiana with Acquisition of Northwest Radiology | LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| INFUSYSTEM | 7,000 | +6,87 % | InfuSystem Holdings, Inc - 8-K, Current Report | ||
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| IRADIMED | 79,00 | -3,07 % | Dividendenbekanntmachungen (17.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERIGO RESOURCES LTD CA03074G1090 0,05 CAD 0,0309 EUR ARES MANAGEMENT CORPORATION US03990B1017 1,12 USD 0,9533 EUR BANK OF COMMUNICATIONS... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 25,500 | +1,47 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery | KIRKLAND, Wash., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced a strategic... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen |
BETA BIONICS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,170 (-1,28 %) liegt der Kurs bei 13,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BETA BIONICS INC finden Sie auf Wallstreet Online.